Prophylaxis of deep vein thrombosis and pulmonary embolism: Current recommendations

Clinical and Applied Thrombosis/Hemostasis

Volumn 4, Issue 2, 1998, Pages 96-104

  Hull, Russell D ^a   Pineo, Graham F ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b THROMBOSIS RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Deep vein thrombosis; Graduated compression stockings; Heparin; Intermittent pneumatic compression; Low molecular weight heparin; Oral anticoagulants; Pulmonary embolism

Indexed keywords

ACETYLSALICYLIC ACID; ARDEPARIN; COUMARIN ANTICOAGULANT; DALTEPARIN; DEXTRAN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; TINZAPARIN; WARFARIN;

BLEEDING; CLINICAL PROTOCOL; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; DRUG INDICATION; HIGH RISK POPULATION; HUMAN; LEG COMPRESSION; LUNG EMBOLISM; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT PLANNING;

EID: 0031978801     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602969800400204     Document Type: Conference Paper

References (96)

1. Dismuke SE, Wagner EH. Pulmonary embolism as a cause of death. The changing mortality in hospitalized patients. JAMA 1986;255:2039.
2. Dalen JE, Alpert JS. Natural history of pulmonary embolism. Prog Cardiovasc Dis 1975;17:257.
3. Anderson FA, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. Arch int Med 1991;151:933.
4. Donaldson GA, Williams C, Scanell J, et al. A reappraisal of the application of the Trendelenburg operation to massive fatal embolism. N Engl J Med 1963;268:171.
5. Clagett GP, Reisch JS. Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis. Ann Surg 1988; 208:227.
6. Collins R, Scrimgeour A, Yusef S, et al. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. N Engl J Med 1988;318:1162
7. Nicolaides AN, Bergqvist D, Hull RD, et al. Prevention of venous thromboembolism. International consensus statement. Int Angiol 1997;16:3.
8. Hull RD, Hirsh J, Carter CJ, et al. Diagnostic efficacy of impedance plethysmography for clinically suspected deep-vein thrombosis: a randomized trial. Ann Int Med 1985;102:21.
9. Huisman MV, Buller HE, ten Cate JW, et al. Serial impedance plethysmography for suspected deep venous thrombosis in outpatients. The Amsterdam General Practitioner Study. N Engl J Med 1986;314:823.
10. Moser KM, Le Moine JR. Is embolic risk conditioned by location of deep venous thrombosis? Ann Int Med 1981;94:439.
11. Huisman MV, Buller HR, ten Cate JW, et al. Management of clinically suspected acute venous thrombosis in outpatients with serial impedance plethysmography in a community hospital setting. Arch Int Med 1989; 149:511.
12. Kakkar VV, Flanc C, Howe CT, et al. Natural history of postoperative deep-vein thrombosis. Lancet 1969;2:230.
13. Lagerstedt CI, Fagher BO, Olsson CG, et al. Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis. Lancet 1985;2:515.
14. Hull RD, Delmore T, Genton E, et al. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. N Engl J Med 1979;301:855.
15. Huisman MV, Buller HR, ten Cate JW, et al. Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis. Chest 1989;95:498.
16. Sevitt S, Gallagher N. Venous thrombosis and pulmonary embolism. A clinico-pathological study in injured and burned patients. Br J Surg 1961;48:475.
17. Mavor GE, Galloway JMD. The iliofemoral venous segment as a source of pulmonary emboli. Lancet 1967;1:871.
18. Hull RD, Hirsh J, Carter CJ, et al. Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolism. Chest 1985;88:819.
19. A collaborative study by the PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism: results of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED). JAMA 1990;263:2753.
20. Kakkar VV, Adams PC. Preventive and therapeutic approach to venous thromboembolism. Can death from pulmonary embolism be prevented? J Am Coll Cardiol 1986;8:146B.
21. Skinner DB, Salzman EW. Anticoagulant prophylaxis in surgical patients. Surg Gynecol Obstet 1967;125:741.
22. Shephard RM, White HA, Shirkey AL. Anticoagulant prophylaxis of thromboembolism in post-surgical patients. Am J Surg 1966; 112:698.
23. International Multicentre Trial: Prevention of fatal postoperative pulmonary embolism by low doses of heparin. Lancet 1975:2:45.
24. Coventry MB, Nolan DR, Beckenbaugh RD. "Delayed" prophylactic anticoagulation: a study of results and complications in 2,012 total hip arthroplasties. J Bone Joint Surg 1973;55A: 1487.
25. Eskeland G, Solheim K, Skhorten F. Anticoagulant prophylaxis, thromboembolism and mortality in elderly patients with hip fracture: a controlled clinical trial. Acta Chir Scand 1986;131:16.
26. Salzman EW, Davies GC. Prophylaxis of venous thromboembolism. Analysis of cost-effectiveness. Ann Surg 1980;191:207.
27. Hull R, Hirsh J, Sackett DL, et al. Cost-effectiveness of primary and secondary prevention of fatal pulmonary embolism in high-risk surgical patients. Can Med Assoc J 1982:127:990.
28. Oster G, Tuden RL, Colditz GA. A cost-effectiveness analysis of prophylaxis against deep vein thrombosis in major orthopedic surgery. JAMA 1987;257:203.
29. Bergqvist D, Matzsch T, Jendteg S, et al. The cost-effectiveness of prevention of post-operative thromboembolism. Acta Chir Scand 1990;556(suppl):36.
30. Hauch O, Kyattar SC, Jorensen LN. Cost-benefit analysis of prophylaxis agiainst deep vein thrombosis in surgery. Semin Thromb Hemost 1991;3(supp 17):280.
31. Kearon C, Hirsh J. Starting prophylaxis for venous thromboembolism postoperatively. Arch Intern Med 1995;155:366.
32. Bergqvist D, Benoni G, Bjorgell O, et al. Low molecular weight heparin (Enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med 1996;335(10): 696.
33. Planes A, Vochelle N, Darmon JY, et al. Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomized comparison of enoxaparin versus placebo. Lancet 1996;348:224.
34. Dahl OE, Andreassen G, Aspelin T, et al. Prolonged thromboprophylaxis after hip replacement surgery - results of a double-blind prospective, randomized, placebo-controlled study with Dalteparin (fragmin). Thromb Haemost 1997;77(1):26.
35. Lassen M, Boris L. Prolonged thromboprophylaxis with low molecular weight heparin (Fragmin) after elective total hip arthroplasty - a placebo controlled study. Thromb Haemost 1995;73: 1104.
36. Clagett GP, Anderson FA, Heit J, et al. Prevention of venous thromboembolism. Chest 1995;108(4):312S.
37. Cook DJ, Guyatt GH, Laupacis A, et al. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1995;108(4):227S.
38. Leyvraz PF, Bachmann F, Hoek J, et al. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin. Br Med J 1991;303:543.
39. Kakkar VV, Cohen AT, Edmonson RA, et al. Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. Lancet 1993;341:259.
40. Kakkar VV, Boeckl O, Boneau B, et al. Efficacy and safety of a low-molecular-weight heparin and standard unfractionated heparin for prophylaxis of postoperative venous thromboembolism: European multicenter trial. World J Surg 1997;21:2.
41. Bergqvist D, Matzsch T, Brumark U, et al. Low-molecular-weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosis. Br J Surg 1988;75:888.
42. Samama M, Bernard P, Bonnardot JP, et al. Low-molecular-weight heparin compared with unfractionated heparin in prevention of postoperative thrombosis. Br J Surg 1988;75:128.
43. The European Fraxiparin Study Group. Comparison of a low-molecular-weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. Br J Surg 1988;75:1058.
44. Caen JP. A randomized double-blind study between a low-molecular-weight heparin Kabi 2165 and standard heparin in the prevention of deep-vein thrombosis in general surgery. A French multicentre trial. Thromb Haemost 1988;59:216.
45. Leizorovicz A, Picolet H, Peyrieux JC, et al. Prevention of peri-operative deep vein thrombosis in general surgery: a multicentre double-blind study comparing two doses of logiparin and standard heparin. Br J Surg 1991;78:412.
46. Nurmohamed MT, Verhaeghe R, Haas S, et al. A comparative trial of a low molecular weight heparin (Enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery. Am J Surg 1995;169:567.
47. Bergqvist D, Burmark US, Flordal PA, et al. Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 500 Xal units in 2070 patients. Br J Surg 1995;82:496.
48. Turpie AGG, Levine MN, Hirsh J, et al. A randomized controlled trial of low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med 1986;315:925.
49. Tørholm C, Broeng L, Jørgensen PS, et al. Thromboprophylaxis by low-molecular-weight heparin in elective hip surgery: a placebo controlled study. J Bone Joint Surg Br 1991;73-B:434.
50. Lassen MR, Borris LC, Christiansen HM, et al. Prevention of thromboembolism in 190 hip arthroplasties. Acta Orthop Scand 1991;62(1):33.
51. The Danish Enoxaparin Study Group. Low-molecular weight heparin (Enoxaparin) vs Dextran 70. Arch Int Med 1991;151:1621.
52. Levine MN, Hirsh J, Gent M, et al. Prevention of deep vein thrombosis after elective hip surgery: a randomized trial comparing low molecular weight heparin with standard unfractionated heparin. Ann Int Med 1991;14(7):545.
53. Eriksson BI, Kälebo P, Anthmyr BA, et al. Prevention of deep vein thrombosis and pulmonary embolism after total hip replacement. J Bone Joint Surg 1991;73-A(4):484.
54. Planes A, Vochelle N, Fagola M, et al. Prevention of deep vein thrombosis after total hip replacement: the effect of low-molecular-weight heparin with spinal and general anaesthesia. J Bone Joint Surg 1991;73-B:418.
55. Colwell CW, Spiro TE, Trowbridge AA, et al. Use of Enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. J Bone Joint Surg 1994;76-A(1):3.
56. Hull RD, Raskob GE, Pineo GF, et al. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med 1993;329:1370.
57. Hamulyak K, Lensing AWA, van der Meer J, et al. Subcutaneous low molecular weight heparin or oral anticoagulants for the prevention of deep vein thrombosis in elective hip and knee replacement? Thromb Haemost 1995;74(6):1428.
58. Leclerc JR, Geerts WH, Desjardins L, et al. Prevention of deep vein thrombosis after major knee surgery - a randomized, double-blind trial comparing a low-molecular-weight heparin fragment (Enoxaparin) to placebo. Thromb Haemost 1992;67(4):417.
59. Leclerc JR, Geerts WH, Desjardins L, et al. Prevention of venous thromboembolism after knee arthroplasty - a randomized, double-blind trial comparing a low molecular weight heparin fragment (Enoxparin) to warfarin [Abstract]. Thromb Haemost 1995;73(6): 1103.
60. Heit J, Berkowitz S, Bona R, et al. Efficacy and safety of Normiflow (a LMWH) compared to warfarin for prevention of venous thromboembolism after total knee replacement: a double-blind, dose-ranging study [Abstract]. Thromb Haemost 1995;73(6):A739.
61. Nurmohamed MT, Rosendaal FR, Büller HR, et al. Low molecular weight heparin in the prophylaxis of venous thrombosis: a metaanalysis. Lancet 1992;340:152.
62. O'Brien BJ, Anderson DR, Goeree R. Cost-effectiveness of enoxparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement. Can Med Assoc J 1994;150(7):1083.
63. Menzin J, Colditz GA, Regan MM, et al. Cost-effectiveness of Enoxaparin vs low dose warfarin in the prevention of deep-vein thrombosis after total hip replacement, surgery. Arch Intern Med 1995;155:757.
64. Hull RD, Raskob GE, Rosenbloom D, et al. Treatment of proximal vein thrombosis with subcutaneous low molecular weight heparin vs intravenous heparin. Arch Intern Med 1997;159:289.
65. Geerts WH, Jay RM, Code KI, et al. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 1996; 335(10):701.
66. Harenberg J, Roebruck P, Heene DL, on behalf of the Heparin Study in Internal Medicine Group. Subcutaneous low molecular weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients. Haemostasis 1996;26: 127.
67. Bergmann JF, Neuhart E. A multicenter randomized double-blind study of Enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly inpatients bedridden for an acute medical illness. Thromb Haemost 1996;7 (4):529.
68. Gallus A, Cade J, Ockelford P, et al. Orgaran (Org 10172) or heparin for preventing venous thromboembolism after elective surgery for malignant disease? A double-blind, randomized multicentre comparison. Thromb Haemost 1993;70:562.
69. Bergqvist D, Kettunen K, Fredin H, et al. Thromboprophylaxis in hip fracture patients - a prospective randomized comparative study between ORG 10172 and dextran. Surgery 1991;109:617.
70. Gerhart TN, Yett HS, Robertson LK, et al. Low-molecular-weight heparinoid compared with warfarin for prophylaxis of deep vein thrombosis in patients who are operated on for fracture of the hip. A prospective, randomized trial. J Bone Joint Surg 1991;73-A(4):494.
71. Hoek J, Nurmohamed MT, ten Cate H, et al. Prevention of deep vein thrombosis following total hip replacement by a low-molecular-weight heparinoid. Thromb Haemost 1989;62(suppl): 1637.
72. Francis CW, Pellegrini VD, Marder VJ, et al. Comparison of warfarin and external pneumatic compression in prevention of venous thrombosis after total hip replacement. JAMA 1992;267(21):2911.
73. Paiement GD, Wessinger SJ, Waltman WC, et al. Low-dose warfarin versus external pneumatic compression. Ann Intern Med 1990;112:423.
74. Francis CW, Pellegrini VD Jr, Leibert KM. Comparison of two warfarin regimens in the prevention of venous thrombosis following total knee replacement. Thromb Haemost 1996;5(75):706.
75. Power PJ, Gent M, Jay R, et al. A randomized trial of less intense postoperative warfarin or aspirin thearpy in the prevention of venous thromboembolism after surgery for fractured hip. Arch Intern Med 1989;149:771.
76. Poller L, McKernan A, Thomson JM et al. Fixed minidose warfarin: a new approach to prophylaxis against venous thrombosis after major surgery. Br Med J 1987;295:1309.
77. Bern MM, Lokich JJ, Wallach SR, et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. Ann Intern Med 1990;112:423.
78. Dale C, Gallus A, Wycherley A, et al. Prevention of venous thrombosis with minidose warfarin after joint replacement. Br Med J 1991;303:224.
79. Roberts VC, Sabri S, Beely AH, et al. The effect of intermittently applied external pressure on the hemodynamies of the lower limb in man. Br J Surg 1972;59:233.
80. Ramos R. Salem BI, Pawlikowski MP, et al. The effieacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery. Chest 1996;109(1):82.
81. Turpie AGG, Gallus A, Beattie WS, et al. Prevention of venous thrombosis in patients with intracranial disease by intermittent pneumatic compression of the calf. Neurology 1997;27:435.
82. Turpie AGG, Delmore T, Hirsh J, et al. Prevention of venous thrombosis by intermittent sequential calf compression in patients with intracranial disease. Thromb Res 1979;16:611.
83. Skillman JJ, Collins RR, Coe NP, et al. Prevention of deep vein thrombosis in neurosurgical patients: a controlled, randomized trial of external pneumatic compression boots. Surgery 1978;83;354.
84. Hull RD, Raskob G, Gent M, et al. Effectiveness of intermittent pneumatic leg compression for preventing deep vein thrombosis after total hip replacement, JAMA 1990;263:2313.
85. Hull RD, Delmore TJ, Hirsh J, et al. Effectiveness of intermittent pulsatile elastic stockings for the prevention of calf and thigh vein thrombosis in patients undergoing elective knee surgery. Thromb Res 1979;16:37.
86. Mckenna R, Galante J, Bachmann F, et al. Prevention of venous thromboembolism after total knee replacement by high-dose aspirin or intermittent calf and thigh compression. Br Med J 1980;1: 514.
87. Meyerowitz BR, Nelson R. Measurement of the velocity of blood in lower limb veins with and without compression surgery. Surgery 1964;56:481.
88. Sigel B, Edelstein AL, Felix WR. Compression of the deep venous system of the lower leg during inactive recumbency. Arch Surg 1973;106:38.
89. Lawrence D, Kakkar VV. Graduated, static, external compression of the lower limb: a physiological assessment. Br J Surg 1980;67: 119.
90. Wells PS, Lensing AWA, Hirsh J. Graduated compression stockings in the prevention of postoperative venous thromboembolism. A meta-analysis. Arch Int Med 1994;154:67.
91. Antiplatelet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy - III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Br Med J 1994;308:235.
92. Eriksson BI, Ekman S, Kalebo P, et al. Prevention of deep-vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393. Lancet 1996;347:635.
93. Eriksson BI, Goteborg SE, Lindbratt S, et al. Prevention of Thromboembolism with use of recombinant hirudin. J Bone Joint Surg. 1997;79-A(3):326.
94. Cairns JA, Lewis HD, Meade TW, et al. Antithrombotic agents in coronary artery disease. Chest 1995;108(4):380S.
95. Sherman DG, Dyken ML, Gent M, et al. Antithrombotic therapy for cerebrovascular disorders. Chest 1995;108(4):444S.
96. Hunt BJ, Dought HA, Majumdar G, et al. Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies. Thromb Haemost 1997;77(1):39.